| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |